P17301 (ITA2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 157.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Integrin alpha-2 Alternative name(s): CD49 antigen-like family member B Collagen receptor Platelet membrane glycoprotein Ia Short name=GPIa VLA-2 subunit alpha CD_antigen=CD49b | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1181 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Integrin alpha-2/beta-1 is a receptor for laminin, collagen, collagen C-propeptides, fibronectin and E-cadherin. It recognizes the proline-hydroxylated sequence G-F-P-G-E-R in collagen. It is responsible for adhesion of platelets and other cells to collagens, modulation of collagen and collagenase gene expression, force generation and organization of newly synthesized extracellular matrix. |
| Subunit structure | Heterodimer of an alpha and a beta subunit. Alpha-2 associates with beta-1. Interacts with HPS5 and RAB21. Binds to human echoviruses 1 and 8 capsid proteins and acts as a receptor for these viruses. Interacts (via ITAG2 I-domain) with rotavirus A VP4; this interaction only occurs in rotavirus integrin-dependent strains, for which ITGA2 acts as a receptor. Ref.5 Ref.6 Ref.7 |
| Subcellular location | |
| Domain | The integrin I-domain (insert) is a VWFA domain. Integrins with I-domains do not undergo protease cleavage. |
| Polymorphism | Position 534 is associated with platelet-specific alloantigen HPA-5 (Br). HPA-5A/Br(a) has Lys-534 and HPA-5B/Br(b) has Glu-534. HPA-5B is involved in neonatal alloimmune thrombocytopenia (NAIT or NATP). The Lys-534-Glu polymorphism may play a role in coronary artery disease (CAD). |
| Sequence similarities | Belongs to the integrin alpha chain family. Contains 7 FG-GAP repeats. Contains 1 VWFA domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ITGB1 | P05556 | 3 | EBI-702960,EBI-703066 | |
| Rab21 | P35282 | 7 | EBI-702960,EBI-1993555 | From a different organism. |
| SHARPIN | Q9H0F6 | 5 | EBI-702960,EBI-3942966 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 29 | 29 | Ref.1 | ||||||||||||||||||||||||||||||||||||
| Chain | 30 – 1181 | 1152 | Integrin alpha-2 | PRO_0000016233 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 30 – 1132 | 1103 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 1133 – 1154 | 22 | Helical; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 1155 – 1181 | 27 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Repeat | 34 – 92 | 59 | FG-GAP 1 | ||||||||||||||||||||||||||||||||||||
| Repeat | 101 – 161 | 61 | FG-GAP 2 | ||||||||||||||||||||||||||||||||||||
| Domain | 188 – 365 | 178 | VWFA | ||||||||||||||||||||||||||||||||||||
| Repeat | 366 – 420 | 55 | FG-GAP 3 | ||||||||||||||||||||||||||||||||||||
| Repeat | 423 – 477 | 55 | FG-GAP 4 | ||||||||||||||||||||||||||||||||||||
| Repeat | 478 – 539 | 62 | FG-GAP 5 | ||||||||||||||||||||||||||||||||||||
| Repeat | 540 – 598 | 59 | FG-GAP 6 | ||||||||||||||||||||||||||||||||||||
| Repeat | 602 – 664 | 63 | FG-GAP 7 | ||||||||||||||||||||||||||||||||||||
| Calcium binding | 499 – 507 | 9 | Potential | ||||||||||||||||||||||||||||||||||||
| Calcium binding | 563 – 571 | 9 | Potential | ||||||||||||||||||||||||||||||||||||
| Calcium binding | 627 – 635 | 9 | Potential | ||||||||||||||||||||||||||||||||||||
| Region | 1155 – 1161 | 7 | Interaction with HPS5 | ||||||||||||||||||||||||||||||||||||
| Motif | 1157 – 1161 | 5 | GFFKR motif | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 105 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 112 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 343 | 1 | N-linked (GlcNAc...) Ref.8 Ref.12 Ref.13 | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 432 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 460 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 475 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 699 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 1057 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 1074 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 1081 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 83 ↔ 92 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 680 ↔ 737 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 789 ↔ 795 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 865 ↔ 876 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1019 ↔ 1050 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1055 ↔ 1060 | By similarity | |||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 534 | 1 | K → E in alloantigen HPA-5B. Ref.3 Ref.16 Ref.17 Corresponds to variant rs1801106 [ dbSNP | Ensembl ]. | VAR_003977 | |||||||||||||||||||||||||||||||||||
| Natural variant | 691 | 1 | N → K. Ref.2 Corresponds to variant rs3212557 [ dbSNP | Ensembl ]. | VAR_029146 | |||||||||||||||||||||||||||||||||||
| Natural variant | 927 | 1 | N → S. Corresponds to variant rs2287870 [ dbSNP | Ensembl ]. | VAR_021855 | |||||||||||||||||||||||||||||||||||
| Natural variant | 1127 | 1 | K → Q. Ref.2 Corresponds to variant rs3212645 [ dbSNP | Ensembl ]. | VAR_020036 | |||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1159 | 1 | F → A: No significant reduction of RAB21-binding by co-immunoprecipitation assay; when associated with A-1160 and A-1162. Ref.7 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1160 | 1 | K → A: No effect on RAB21-binding. Significant reduction of RAB21-binding; when associated with A-1161. Shows defective cytokinesis on collagen, but not on fibronectin; when associated with A-1161. Ref.7 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1161 | 1 | R → A: Significant reduction of RAB21-binding; when associated with A-1160. Shows defective cytokinesis on collagen, but not on fibronectin; when associated with A-1160. Ref.7 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1162 | 1 | K → A: No significant reduction of RAB21-binding by co-immunoprecipitation assay; when associated with A-1159 and A-1160. Ref.7 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1162 | 1 | K → P: Markedly weakens RAB21-binding. Shows defective cytokinesis on collagen, but not on fibronectin. Ref.7 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1164 | 1 | E → A: Significant reduction of RAB21-binding; when associated with A-1160; A-1161 and A-1165. Ref.7 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1165 | 1 | K → A: Significant reduction of RAB21-binding; when associated with A-1160; A-1161 and A-1164. Ref.7 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 17 | 1 | L → V in AAA16619. Ref.3 | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 173 – 180 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 188 – 200 | 13 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 208 – 224 | 17 | |||||||||||||||||||||||||||||||||||||
| Turn | 226 – 228 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 232 – 241 | 10 | |||||||||||||||||||||||||||||||||||||
| Helix | 252 – 262 | 11 | |||||||||||||||||||||||||||||||||||||
| Helix | 266 – 268 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 274 – 284 | 11 | |||||||||||||||||||||||||||||||||||||
| Helix | 289 – 291 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 292 – 301 | 10 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 304 – 311 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 313 – 317 | 5 | |||||||||||||||||||||||||||||||||||||
| Helix | 323 – 332 | 10 | |||||||||||||||||||||||||||||||||||||
| Helix | 337 – 340 | 4 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 341 – 347 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 348 – 353 | 6 | |||||||||||||||||||||||||||||||||||||
| Helix | 354 – 362 | 9 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa): homology to other integrins and the presence of a possible collagen-binding domain." Takada Y., Hemler M.E. J. Cell Biol. 109:397-407(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 30-44. Tissue: Endothelial cell. |
| [2] | SeattleSNPs variation discovery resource Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LYS-691 AND GLN-1127. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT GLU-534. |
| [4] | "The human alpha 2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression." Zutter M.M., Santoro S.A., Painter A.S., Tsung Y.L., Gafford A. J. Biol. Chem. 269:463-469(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21. |
| [5] | "Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2." Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., Finberg R.W. J. Virol. 67:6847-6852(1993) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUMAN ECHOVIRUS 1 AND HUMAN ECHOVIRUS 8 CAPSID PROTEINS. |
| [6] | "Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry." Graham K.L., Halasz P., Tan Y., Hewish M.J., Takada Y., Mackow E.R., Robinson M.K., Coulson B.S. J. Virol. 77:9969-9978(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ROTAVIRUS A VP4. |
| [7] | "Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins." Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M., Ivaska J. J. Cell Biol. 173:767-780(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RAB21, MUTAGENESIS OF PHE-1159; LYS-1160; ARG-1161; LYS-1162; GLU-1164 AND LYS-1165. |
| [8] | "Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach." Lewandrowski U., Moebius J., Walter U., Sickmann A. Mol. Cell. Proteomics 5:226-233(2006) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-343, MASS SPECTROMETRY. Tissue: Platelet. |
| [9] | "Integrin trafficking regulated by Rab21 is necessary for cytokinesis." Pellinen T., Tuomi S., Arjonen A., Wolf M., Edgren H., Meyer H., Grosse R., Kitzing T., Rantala J.K., Kallioniemi O., Faessler R., Kallio M., Ivaska J. Dev. Cell 15:371-385(2008) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF LYS-1160; ARG-1161 AND LYS-1162. |
| [10] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Platelet. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [12] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-343, MASS SPECTROMETRY. Tissue: Liver. |
| [13] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-343, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [14] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [15] | "Crystal structure of the I domain from integrin alpha2beta1." Emsley J., King S.L., Bergelson J.M., Liddington R.C. J. Biol. Chem. 272:28512-28517(1997) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 168-368. |
| [16] | "The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2)." Santoso S., Kalb R., Walka M., Kiefel V., Mueller-Eckhardt C., Newman P.J. J. Clin. Invest. 92:2427-2432(1993) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GLU-534. |
| [17] | "The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction." Kroll H., Gardemann A., Fechter A., Haberbosch W., Santoso S. Thromb. Haemost. 83:392-396(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GLU-534. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X17033 mRNA. Translation: CAA34894.1. AF512556 Genomic DNA. Translation: AAM34795.1. L24121 Genomic DNA. Translation: AAA16619.2. | ||||||||||||||||||||||||||||||
| IPI | IPI00013744. | ||||||||||||||||||||||||||||||
| PIR | A33998. | ||||||||||||||||||||||||||||||
| RefSeq | NP_002194.2. NM_002203.3. | ||||||||||||||||||||||||||||||
| UniGene | Hs.482077. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P17301. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| DIP | DIP-67N. | ||||||||||||||||||||||||||||||
| IntAct | P17301. 8 interactions. | ||||||||||||||||||||||||||||||
| MINT | MINT-5004079. | ||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000296585. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P17301. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 124942. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | P17301. | ||||||||||||||||||||||||||||||
| PRIDE | P17301. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 3673. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000296585; ENSP00000296585; ENSG00000164171. | ||||||||||||||||||||||||||||||
| GeneID | 3673. | ||||||||||||||||||||||||||||||
| KEGG | hsa:3673. | ||||||||||||||||||||||||||||||
| UCSC | uc003joy.3. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 3673. | ||||||||||||||||||||||||||||||
| GeneCards | GC05P052321. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0032121. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:6137. ITGA2. | ||||||||||||||||||||||||||||||
| HPA | CAB017690. | ||||||||||||||||||||||||||||||
| MIM | 192974. gene+phenotype. | ||||||||||||||||||||||||||||||
| neXtProt | NX_P17301. | ||||||||||||||||||||||||||||||
| PharmGKB | PA204. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | NOG237277. | ||||||||||||||||||||||||||||||
| HOGENOM | HOG000059610. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG006185. | ||||||||||||||||||||||||||||||
| InParanoid | P17301. | ||||||||||||||||||||||||||||||
| KO | K06481. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG45B1DV. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | arf6_traffickingpathway. Arf6 trafficking events. syndecan_2_pathway. Syndecan-2-mediated signaling events. lymphangiogenesis_pathway. VEGFR3 signaling in lymphatic endothelium. | ||||||||||||||||||||||||||||||
| Reactome | REACT_111045. Developmental Biology. REACT_111102. Signal Transduction. REACT_604. Hemostasis. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P17301. | ||||||||||||||||||||||||||||||
| Bgee | P17301. | ||||||||||||||||||||||||||||||
| CleanEx | HS_ITGA2. | ||||||||||||||||||||||||||||||
| Genevestigator | P17301. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000164171. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR013517. FG-GAP. IPR013519. Int_alpha_beta-p. IPR000413. Integrin_alpha. IPR013649. Integrin_alpha-2. IPR018184. Integrin_alpha_C_CS. IPR002035. VWF_A. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF01839. FG-GAP. 1 hit. PF08441. Integrin_alpha2. 1 hit. PF00092. VWA. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PRINTS | PR01185. INTEGRINA. | ||||||||||||||||||||||||||||||
| SMART | SM00191. Int_alpha. 5 hits. SM00327. VWA. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS51470. FG_GAP. 7 hits. PS00242. INTEGRIN_ALPHA. 1 hit. PS50234. VWFA. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| BindingDB | P17301. | ||||||||||||||||||||||||||||||
| ChEMBL | CHEMBL4998. | ||||||||||||||||||||||||||||||
| EvolutionaryTrace | P17301. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 3673. | ||||||||||||||||||||||||||||||
| NextBio | 14377. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | ITA2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P17301 Secondary accession number(s): Q14595 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
